Cargando…
GRAMD4 inhibits tumour metastasis by recruiting the E3 ligase ITCH to target TAK1 for degradation in hepatocellular carcinoma
BACKGROUND: Aberrant TAK1 (transforming growth factor β‐activated kinase 1) activity is known to be involved in a variety of malignancies, but the regulatory mechanisms of TAK1 remain poorly understood. GRAMD4 (glucosyltransferase Rab‐like GTPase activator and myotubularin domain containing 4) is a...
Autores principales: | Ge, Qian yun, Chen, Jin, Li, Gan xun, Tan, Xiao long, Song, Jia, Ning, Deng, Mo, Jie, Du, Peng cheng, Liu, Qiu meng, Liang, Hui fang, Ding, Ze yang, Zhang, Xue wu, Zhang, Bi xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597946/ https://www.ncbi.nlm.nih.gov/pubmed/34841685 http://dx.doi.org/10.1002/ctm2.635 |
Ejemplares similares
-
The E3 ligase Itch and deubiquitinase Cyld co-operatively regulate Tak1 and inflammation
por: Ahmed, Neesar, et al.
Publicado: (2011) -
Ubiquitin ligase ITCH recruitment suppresses the aggregation and cellular toxicity of cytoplasmic misfolded proteins
por: Chhangani, Deepak, et al.
Publicado: (2014) -
GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment
por: Liu, Yifu, et al.
Publicado: (2022) -
ITCH E3 ligase in ATM network
por: Stagni, Venturina, et al.
Publicado: (2014) -
Ubiquitin E3 ligase Itch negatively regulates osteoblast function by promoting proteasome degradation of osteogenic proteins
por: Liu, J., et al.
Publicado: (2017)